Bokf, Na Novo Nordisk A S Transaction History

Bokf, Na

  • $5.65 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
SELL
$122.71 - $146.91 $70,067 - $83,885
-571 Reduced 7.33%
7,221 $1.03 Million
Q1 2024

May 15, 2024
BUY
$102.11 - $135.92 $191,047 - $254,306
1,871 Added 31.6%
7,792 $1 Million
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $84,619 - $101,653
964 Added 19.45%
5,921 $612,000
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $216,982 - $476,102
2,386 Added 92.8%
4,957 $450,000
Q2 2023

Aug 21, 2023
SELL
$155.98 - $172.65 $195,598 - $216,503
-1,254 Reduced 32.78%
2,571 $416,000
Q1 2023

May 11, 2023
SELL
$132.34 - $159.14 $5.7 Million - $6.85 Million
-43,070 Reduced 91.84%
3,825 $608,000
Q4 2022

Feb 13, 2023
SELL
$102.55 - $135.33 $308,675 - $407,343
-3,010 Reduced 6.03%
46,895 $6.35 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $40,494 - $49,695
-425 Reduced 0.84%
49,905 $4.97 Million
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $31,384 - $37,030
-304 Reduced 0.6%
50,330 $5.61 Million
Q1 2022

May 13, 2022
SELL
$93.1 - $112.54 $300,061 - $362,716
-3,223 Reduced 5.98%
50,634 $5.62 Million
Q4 2021

Mar 11, 2022
BUY
$95.88 - $117.08 $317,075 - $387,183
3,307 Added 6.54%
53,857 $6.03 Million
Q3 2021

Nov 10, 2021
BUY
$84.42 - $106.62 $239,583 - $302,587
2,838 Added 5.95%
50,550 $4.85 Million
Q1 2021

Apr 21, 2021
SELL
$67.06 - $75.82 $245,171 - $277,197
-3,656 Reduced 7.12%
47,712 $3.22 Million
Q4 2020

Feb 12, 2021
BUY
$63.89 - $73.8 $140,366 - $162,138
2,197 Added 4.47%
51,368 $3.59 Million
Q3 2020

Oct 30, 2020
SELL
$63.69 - $70.22 $8,980 - $9,901
-141 Reduced 0.29%
49,171 $3.41 Million
Q2 2020

Aug 12, 2020
BUY
$58.54 - $67.94 $19,025 - $22,080
325 Added 0.66%
49,312 $3.23 Million
Q1 2020

May 13, 2020
SELL
$49.46 - $64.78 $8,853 - $11,595
-179 Reduced 0.36%
48,987 $2.95 Million
Q4 2019

Feb 12, 2020
SELL
$49.86 - $58.26 $31,910 - $37,286
-640 Reduced 1.28%
49,166 $2.85 Million
Q3 2019

Nov 13, 2019
BUY
$47.54 - $53.43 $234,467 - $263,516
4,932 Added 10.99%
49,806 $2.58 Million
Q2 2019

Aug 14, 2019
BUY
$46.79 - $52.47 $1,778 - $1,993
38 Added 0.08%
44,874 $2.29 Million
Q1 2019

May 15, 2019
BUY
$46.36 - $52.63 $6,397 - $7,262
138 Added 0.31%
44,836 $2.35 Million
Q4 2018

Feb 13, 2019
SELL
$41.54 - $47.25 $28,911 - $32,886
-696 Reduced 1.53%
44,698 $2.06 Million
Q3 2018

Nov 13, 2018
BUY
$46.76 - $51.24 $33,059 - $36,226
707 Added 1.58%
45,394 $2.14 Million
Q2 2018

Aug 13, 2018
SELL
$44.29 - $50.42 $14,172 - $16,134
-320 Reduced 0.71%
44,687 $2.06 Million
Q1 2018

May 14, 2018
BUY
$48.49 - $58.14 $60,903 - $73,023
1,256 Added 2.87%
45,007 $2.22 Million
Q4 2017

Feb 14, 2018
BUY
$47.53 - $53.73 $355,144 - $401,470
7,472 Added 20.6%
43,751 $2.35 Million
Q3 2017

Nov 14, 2017
SELL
$41.15 - $49.22 $452 - $541
-11 Reduced 0.03%
36,279 $1.75 Million
Q2 2017

Aug 14, 2017
BUY
N/A
36,290
36,290 $1.56 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email